Literature DB >> 21794091

Clinical and plasma proteomic markers correlating with chronic kidney disease after liver transplantation.

J Levitsky1, D R Salomon, M Abecassis, P Langfelder, S Horvath, J Friedewald, E Wang, S M Kurian, T Mondala, S Gil, R McDade, K Ballard, L Gallon.   

Abstract

Chronic kidney disease (CKD) occurs frequently after liver transplantation (LT) and is associated with significant morbidity and mortality. Thus, there is a pressing need to identify characteristics and biomarkers diagnostic of CKD to enable early diagnosis allowing preemptive interventions, as well as mechanistic insights into the progression from kidney injury to irreversible kidney failure. We analyzed 342 patients who had baseline glomerular filteration rate (GFR) >60 at the time of LT and are now >3 years post-LT. Risk factors for post-LT CKD were compared between three different groups defined by current GFR: >90 (n = 40), 60-90 (n = 146) and <60 (n = 156) mL/min. Age, cyclosporine use and pre-LT GFR were independently associated with new onset CKD. A subset (n = 64) without viral/immune disease or graft dysfunction underwent multianalyte plasma proteomic evaluations for correlation with CKD. Plasma proteomic analysis of two independent cohorts, test (n = 22) and validation (n = 42), identified 10 proteins highly associated with new onset CKD. In conclusion, we have identified clinical characteristics and a unique plasma proteomic signature correlating with new onset CKD after LT. These preliminary results are currently being validated in a prospective, multicenter study to determine if this signature precedes the onset of CKD and resolves with early interventions aimed at preserving kidney function. © 2011 The Authors Journal compilation
© 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21794091      PMCID: PMC3166389          DOI: 10.1111/j.1600-6143.2011.03669.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Authors:  Yan Yu; Hong Jin; Daniel Holder; Josef S Ozer; Stephanie Villarreal; Paul Shughrue; Shu Shi; David J Figueroa; Holly Clouse; Ming Su; Nagaraja Muniappa; Sean P Troth; Wendy Bailey; John Seng; Amy G Aslamkhan; Douglas Thudium; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

3.  Plasma factor VII: a potential marker of pre-eclampsia.

Authors:  Luci M Dusse; Maria G Carvalho; Alan J Cooper; Bashir A Lwaleed
Journal:  Thromb Res       Date:  2010-11-21       Impact factor: 3.944

4.  Stem cell factor, interleukin-16, and interleukin-2 receptor alpha are predictive biomarkers for delayed and slow graft function.

Authors:  N Alachkar; R Ugarte; E Huang; K L Womer; R Montgomery; E Kraus; H Rabb
Journal:  Transplant Proc       Date:  2010-11       Impact factor: 1.066

5.  The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.

Authors:  Neil Boudville; Muna Salama; Gary P Jeffrey; Paolo Ferrari
Journal:  Nephrol Dial Transplant       Date:  2009-06-08       Impact factor: 5.992

6.  Identification of Apolipoprotein AI as a serum biomarker of chronic kidney disease in liver transplant recipients, using proteomic techniques.

Authors:  Aisling O'Riordan; Olwyn Johnston; Tara McMorrow; Kieran Wynne; Patricia Maguire; John E Hegarty; Aidan McCormick; Alan J Watson; Gerard Cagney; William M Gallagher; Michael P Ryan
Journal:  Proteomics Clin Appl       Date:  2008-08-14       Impact factor: 3.494

7.  Fatty acid-binding protein as marker for renal injury.

Authors:  Maurice M A L Pelsers
Journal:  Scand J Clin Lab Invest Suppl       Date:  2008

Review 8.  Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study.

Authors:  Michael G Shlipak; Linda F Fried; Catherine Stehman-Breen; David Siscovick; Anne B Newman
Journal:  Am J Geriatr Cardiol       Date:  2004 Mar-Apr

9.  Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III.

Authors:  Doris T Chan; Gursharan K Dogra; Ashley B Irish; Esther M Ooi; P Hugh Barrett; Dick C Chan; Gerald F Watts
Journal:  J Lipid Res       Date:  2009-06-21       Impact factor: 5.922

10.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

View more
  8 in total

1.  Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.

Authors:  Ellen R Brooks; Bernd Hoppe; Dawn S Milliner; Eduardo Salido; John Rim; Leah M Krevitt; Julie B Olson; Heather E Price; Gulsah Vural; Craig B Langman
Journal:  Am J Nephrol       Date:  2016-05-03       Impact factor: 3.754

2.  CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model.

Authors:  Yiing Lin; Pamela T Manning; Jianluo Jia; Joseph P Gaut; Zhenyu Xiao; Benjamin J Capoccia; Chun-Cheng Chen; Ronald R Hiebsch; Gundumi Upadhya; Thalachallour Mohanakumar; William A Frazier; William C Chapman
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

3.  Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients.

Authors:  Josh Levitsky; James M Mathew; Michael Abecassis; Anat Tambur; Joseph Leventhal; Dhivya Chandrasekaran; Nancy Herrera; Patrice Al-Saden; Lorenzo Gallon; Anmaar Abdul-Nabi; Guang-Yu Yang; Sunil M Kurian; Daniel R Salomon; Joshua Miller
Journal:  Hepatology       Date:  2012-07-17       Impact factor: 17.425

Review 4.  Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.

Authors:  J Levitsky; J G O'Leary; S Asrani; P Sharma; J Fung; A Wiseman; C U Niemann
Journal:  Am J Transplant       Date:  2016-04-22       Impact factor: 8.086

Review 5.  Biomarkers in Transplantation--Proteomics and Metabolomics.

Authors:  Uwe Christians; Jelena Klawitter; Jost Klawitter
Journal:  Ther Drug Monit       Date:  2016-04       Impact factor: 3.681

6.  Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation.

Authors:  Josh Levitsky; Sumeet K Asrani; Goran Klintmalm; Thomas Schiano; Adyr Moss; Kenneth Chavin; Charles Miller; Kexin Guo; Lihui Zhao; Linda W Jennings; Merideth Brown; Brian Armstrong; Michael Abecassis
Journal:  Hepatology       Date:  2020-01-28       Impact factor: 17.425

7.  Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation.

Authors:  Ling Pan; Zili Lyu; Benjamin Adam; Gang Zeng; Zijie Wang; Yuchen Huang; Zahidur Abedin; Parmjeet Randhawa
Journal:  Transplant Direct       Date:  2018-02-02

8.  Effect of Immunosuppressive Therapy on Proteinogram in Rats.

Authors:  Karolina Kędzierska; Krzysztof Sindrewicz; Katarzyna Sporniak-Tutak; Joanna Bober; Małgorzata Stańczyk-Dunaj; Barbara Dołęgowska; Robert Kaliszczak; Jerzy Sieńko; Joanna Kabat-Koperska; Edyta Gołembiewska; Kazimierz Ciechanowski
Journal:  Med Sci Monit       Date:  2016-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.